T. Rowe Price Associates’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-100,000
| Closed | -$361K | – | 2955 |
|
|
2022
Q4 | $361K | Sell |
100,000
-12,576
| -11% | -$45.4K | ﹤0.01% | 2298 |
|
|
2022
Q3 | $997K | Sell |
112,576
-15,418
| -12% | -$137K | ﹤0.01% | 1750 |
|
|
2022
Q2 | $986K | Sell |
127,994
-31,601
| -20% | -$243K | ﹤0.01% | 1897 |
|
|
2022
Q1 | $1.51M | Hold |
159,595
| – | – | ﹤0.01% | 1802 |
|
|
2021
Q4 | $1.11M | Hold |
159,595
| – | – | ﹤0.01% | 1982 |
|
|
2021
Q3 | $1.52M | Hold |
159,595
| – | – | ﹤0.01% | 1843 |
|
|
2021
Q2 | $1.59M | Buy |
+159,595
| New | +$1.59M | ﹤0.01% | 1839 |
|
|
2018
Q3 | – | Sell |
-84,401
| Closed | -$3.62M | – | 2600 |
|
|
2018
Q2 | $3.62M | Sell |
84,401
-72,177
| -46% | -$3.09M | ﹤0.01% | 1477 |
|
|
2018
Q1 | $10.2M | Sell |
156,578
-21,226
| -12% | -$1.39M | ﹤0.01% | 1324 |
|
|
2017
Q4 | $13M | Buy |
177,804
+35,068
| +25% | +$2.56M | ﹤0.01% | 1280 |
|
|
2017
Q3 | $13.1M | Buy |
142,736
+76,847
| +117% | +$7.04M | ﹤0.01% | 1278 |
|
|
2017
Q2 | $4.36M | Buy |
+65,889
| New | +$4.36M | ﹤0.01% | 1428 |
|